RECRUITING

Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study plans to learn more about what patients think about screening for esophageal cancer (EAC) and Barrett's esophagus (BE); a pre-cancerous condition associated with esophageal cancer. The plan is to use this information to modify screening practices in the United States with the goal to decrease the number of people who die from esophageal cancer.

Official Title

Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests: A Discrete Choice-Based Conjoint Analysis

Quick Facts

Study Start:2024-11-01
Study Completion:2029-03-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06693622

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 89 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Provision to sign and date the consent form.
  2. * Stated willingness to comply with all study procedures and be available for the duration of the study.
  3. * Individual has 3 or more established risk factors for BE (age \> 50 years, chronic GERD, male, white race, smoking, obesity, family history of BE/EAC).
  1. * Unable to consent.
  2. * Prior diagnosis of BE/EAC.
  3. * Life limiting comorbidity/ disability.
  4. * Active dementia/ cognitive impairment.
  5. * Incarcerated.

Contacts and Locations

Study Contact

Alexa DeBord, MS
CONTACT
303-724-0432
alexa.debord@cuanschutz.edu

Principal Investigator

Sachin Wani, MD
PRINCIPAL_INVESTIGATOR
University of Colorado - Anschutz Medical Campus
Jennifer Kolb, MD, MS
PRINCIPAL_INVESTIGATOR
University of California, Los Angeles

Study Locations (Sites)

University of Colorado Anschutz Medical Campus
Aurora, Colorado, 80045
United States

Collaborators and Investigators

Sponsor: University of Colorado, Denver

  • Sachin Wani, MD, PRINCIPAL_INVESTIGATOR, University of Colorado - Anschutz Medical Campus
  • Jennifer Kolb, MD, MS, PRINCIPAL_INVESTIGATOR, University of California, Los Angeles

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-11-01
Study Completion Date2029-03-01

Study Record Updates

Study Start Date2024-11-01
Study Completion Date2029-03-01

Terms related to this study

Keywords Provided by Researchers

  • Gastroesophageal Reflux Disease
  • Barrett's Esophagus
  • Barrett's Esophagus Screening
  • BE
  • GERD

Additional Relevant MeSH Terms

  • Gastro Esophageal Reflux Disease
  • Barrett Esophagus